BioEcho Life Sciences develops innovative products that drastically improve the quality, convenience, and speed of standard molecular protocols. The EchoLUTION technology consists of an efficient and gentle lysis, followed by a unique single-step centrifugation, which provides a reduction of procedural steps compared to conventional kits, and considerably reduces plastic waste.
European Commission calls for reversal of Illumina’s $7bn Grail merger
Latest NewsThe European Commission has now recommended concrete steps that, while not yet final, would require Illumina to "swiftly" reverse its controversial $7.1bn acquisition of Grail.
Why we need the switch from oil to biotech now
OpinionOur species – modern humans, or homo sapiens sapiens – has ever striven for progress. And progress was greatly enabled by fire, a fundamental chemical phenomenon that allows the fast release of large amounts of energy.
BioNTech and Ryvu Therapeutics enter into global collaboration
Latest NewsRenewed focus on cancer: COVID-19 vaccine company BioNTech SE (Nasdaq: BNTX) and Ryvu Therapeutics S.A., located in Krakow (Warsaw Stock Exchange: RVU), a Polish clinical-stage cancer therapeutics development company, announced that the companies have entered into a research collaboration for several multi-target immunotherapy programmes, as well as an exclusive licensing agreement for Ryvu’s STING agonist portfolio as stand-alone small molecules.
Amsterdam Neogene Therapeutics aquired by AstraZeneca
Latest NewsAstraZeneca announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company spezialised in next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for targeting cancer. The acquisition delivers an initial payment of $200m on deal closing, and a further up to $120m in both contingent milestones-based and non-contingent consideration.
Novo Nordisk funds API manufacturing with €726m
Latest NewsNovo Nordisk A/S invests €726m to expand facilities and to produce APIs to supply the company’s global clinical trials.
SOTIO licences first cancer ADC from LegoChem Biosciences
Latest NewsSOTIO Biotech a.s. has exercised its first of five exclusive, target-specific options for antibody-drug conjugate (ADC) SOT106 under its agreement with LegoChem Biosciences Inc.
British AI provider raises $33m in Series A financing
Latest NewsLondon-based computer vision specialist V7 Ltd has baged $33m in Series A financing co-led by AI-focused Radical Ventures and Temasek.
Growing investor interest in biotechnology
Latest NewsLatest investment trends were presented by BIOTECH Insight at the start of the German Equity Forum
C4X Discovery Holdings inks $402m deal with AstraZeneca
Latest NewsC4X Discovery Holdings plc has exclusively licenced its NRF2 Activator programme to AstraZeneca and has got an upfront payment of $2m.
Speedy DNA extraction from buccal swabs & FFPE samples
Sponsored PublicationsBioEcho Life Sciences develops innovative products that drastically improve the quality, convenience, and speed of standard molecular protocols. The EchoLUTION technology consists of an efficient and gentle lysis, followed by a unique single-step centrifugation, which provides a reduction of procedural steps compared to conventional kits, and considerably reduces plastic waste.